Propelling Biosimilars Forward: Speed Meets Precision With Cytiva Process Development Services

As patents for blockbuster biologics expire, the biosimilars market is entering a phase of rapid growth, creating both opportunity and pressure for manufacturers. Success hinges on optimizing process development to balance speed, precision, and regulatory compliance. Explore strategies to streamline later-stage biomanufacturing, including mechanistic modeling and digital twins for faster scale-up, risk-based validation approaches for sterile filtration, and IoT-driven predictive maintenance to minimize downtime. A featured case study demonstrates how a biopharma company accelerated biosimilar monoclonal antibody production by converting stainless steel processes to single-use technologies and leveraging expert tech transfer support. Whether you’re navigating regulatory complexities or aiming to reduce time-to-market, these insights can help you deliver affordable therapies efficiently.

Access the full e-book to learn practical steps for advancing your biosimilar strategy.